Shares of Medicure Inc. (CVE:MPH – Get Free Report) reached a new 52-week low on Monday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 1000 shares changing hands. The stock had previously closed at C$0.87.
Medicure Stock Performance
The stock has a market capitalization of C$8.67 million, a P/E ratio of -3.32 and a beta of 0.90. The company has a quick ratio of 1.29, a current ratio of 1.87 and a debt-to-equity ratio of 2.06. The company has a 50-day moving average price of C$0.92 and a two-hundred day moving average price of C$0.99.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
